Renal I/R injury is widespread in clinical practice, commonly observed in conditions such as shock, trauma, renal transplantation, urology, and cardiovascular surgery, and can lead to a rapid decline in kidney function and increase patient mortality
Product Attributes CAS # : CJC-1295 (No-DAC) 863288-34-0
For GHK-Cu, the analysis should detect a prominent peak corresponding to the expected molecular weight of the GHK-Cu complex (~403.9 Da for the [M+H] adduct)
Human safety data for injectable use remain limited, and the FDA has identified potential concerns involving immunogenicity, peptide aggregation and impurities in compounded injectable formulations
REE binding is comparatively mature: lanmodulin (LanM) and derivatives deliver high affinity and have enabled separation prototypes